Literature DB >> 21669280

Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals.

Caroline Bauch1, Susanne N Kolle, Eric Fabian, Christina Pachel, Tzutzuy Ramirez, Benjamin Wiench, Christoph J Wruck, Bennard van Ravenzwaay, Robert Landsiedel.   

Abstract

Allergic contact dermatitis is induced by repeated skin contact with an allergen. Assessment of the skin sensitizing potential of chemicals, agrochemicals, and especially cosmetic ingredients is currently performed with the use of animals. Animal welfare and EU legislation demand animal-free alternatives reflected in a testing and marketing ban for cosmetic ingredients beginning in 2013. The underlying mechanisms of induction and elicitation of skin sensitization are complex and a chemical needs to comply several properties being skin sensitizing. To account for the multitude of events in the induction of skin sensitization an in vitro test system will consist of a battery of various tests. Currently, we performed intralaboratory validations of four assays addressing three different events during induction of skin sensitization. (1) The Direct Peptide Reactivity Assay (DPRA) according to Gerberick and co-workers (Gerberick et al., 2004) using synthetic peptides and HPLC analysis. (2) Two dendritic cell activation assays based on the dendritic cell like cell lines U-937 and THP-1 and flow cytometric detection of the maturation markers CD54 and/or CD86 (Ashikaga et al., 2006; Python et al., 2007; Sakaguchi et al., 2006). (3) Antioxidant response element (ARE)-dependent gene activity in a HaCaT reporter gene cell line (Emter et al., 2010). We present the results of our intralaboratory validation of these assays with 23 substances of known sensitizing potential. The sensitivity, specificity, and accuracy of the individual tests were obtained by comparison to human epidemiological data as well as to data from animal tests such as the local lymph node assay.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669280     DOI: 10.1016/j.tiv.2011.05.030

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

Review 1.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

2.  Prediction of skin sensitization potency using machine learning approaches.

Authors:  Qingda Zang; Michael Paris; David M Lehmann; Shannon Bell; Nicole Kleinstreuer; David Allen; Joanna Matheson; Abigail Jacobs; Warren Casey; Judy Strickland
Journal:  J Appl Toxicol       Date:  2017-01-10       Impact factor: 3.446

3.  Pyridoxylamine reactivity kinetics as an amine based nucleophile for screening electrophilic dermal sensitizers.

Authors:  Itai Chipinda; Wilbes Mbiya; Risikat Ajibola Adigun; Moshood K Morakinyo; Brandon F Law; Reuben H Simoyi; Paul D Siegel
Journal:  Toxicology       Date:  2013-12-12       Impact factor: 4.221

4.  Integrated decision strategies for skin sensitization hazard.

Authors:  Judy Strickland; Qingda Zang; Nicole Kleinstreuer; Michael Paris; David M Lehmann; Neepa Choksi; Joanna Matheson; Abigail Jacobs; Anna Lowit; David Allen; Warren Casey
Journal:  J Appl Toxicol       Date:  2016-02-06       Impact factor: 3.446

Review 5.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

6.  Multivariate models for prediction of human skin sensitization hazard.

Authors:  Judy Strickland; Qingda Zang; Michael Paris; David M Lehmann; David Allen; Neepa Choksi; Joanna Matheson; Abigail Jacobs; Warren Casey; Nicole Kleinstreuer
Journal:  J Appl Toxicol       Date:  2016-08-02       Impact factor: 3.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.